PAPER Schapira AH

Mitochondria in the aetiology and pathogenesis of Parkinson's disease.

Lancet Neurol. 2008 Jan;7(1):97-109. PubMed: 18093566

PAPER Ravenstijn PG, Merlini M, Hameetman M, Murray TK, Ward MA, Lewis H, Ball G, Mottart C, de Ville de Goyet C, Lemarchand T, van Belle K, O'Neill MJ, Danhof M, de Lange EC

The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments.

J Pharmacol Toxicol Methods. 2008 Mar-Apr;57(2):114-30. PubMed: 18155613

PAPER Ghosh JG, Houck SA, Clark JI

Interactive sequences in the molecular chaperone, human alphaB crystallin modulate the fibrillation of amyloidogenic proteins.

Int J Biochem Cell Biol. 2008;40(5):954-67. PubMed: 18162431

PAPER Outeiro TF, Kazantsev A

Drug Targeting of alpha-Synuclein Oligomerization in Synucleinopathies.

Perspect Medicin Chem. 2008;2:41-9. PubMed: 19787096

PAPER Theuns J, Van Broeckhoven C

alpha-Synuclein gene duplications in sporadic Parkinson disease.

Neurology. 2008 Jan 1;70(1):7-9. PubMed: 18166703

PAPER Poewe W

Dysautonomia and cognitive dysfunction in Parkinson's disease.

Mov Disord. 2007 Sep;22 Suppl 17:S374-8. PubMed: 18175399

PAPER Smith DP, Tew DJ, Hill AF, Bottomley SP, Masters CL, Barnham KJ, Cappai R

Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein.

Biochemistry. 2008 Feb 5;47(5):1425-34. PubMed: 18179253

PAPER Herrera AJ, de Pablos RM, Carreño-Müller E, Villarán RF, Venero JL, Tomás-Camardiel M, Cano J, Machado A

The intrastriatal injection of thrombin in rat induced a retrograde apoptotic degeneration of nigral dopaminergic neurons through synaptic elimination.

J Neurochem. 2008 May;105(3):750-62. PubMed: 18179476

PAPER Kirik D, Gai WP, Jensen PH

Is alpha-synuclein the culprit of the Parkinsonian neurodegeneration?

Exp Neurol. 2008 Jan;209(1):3-4. PubMed: 18179907

PAPER Barbour R, Kling K, Anderson JP, Banducci K, Cole T, Diep L, Fox M, Goldstein JM, Soriano F, Seubert P, Chilcote TJ

Red blood cells are the major source of alpha-synuclein in blood.

Neurodegener Dis. 2008;5(2):55-9. PubMed: 18182779

PAPER Reynolds AL, Farrar GJ, Humphries P, Kenna PF

Variation in the electroretinogram of C57BL/6 substrains of mouse.

Adv Exp Med Biol. 2008;613:383-91. PubMed: 18188968

PAPER Engelender S

Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease.

Autophagy. 2008 Apr;4(3):372-4. PubMed: 18216494

PAPER Alafuzoff I, Parkkinen L, Al-Sarraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Kamphorst W, King A, Korkolopoulou P, Kovács GG, Larionov S, Meyronet D, Monoranu C, Morris J, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Streichenberger N, Thal DR, Kretzschmar H,

Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium.

J Neuropathol Exp Neurol. 2008 Feb;67(2):125-43. PubMed: 18219257

PAPER Golovko MY, Murphy EJ

Brain prostaglandin formation is increased by alpha-synuclein gene-ablation during global ischemia.

Neurosci Lett. 2008 Feb 27;432(3):243-7. PubMed: 18226447

PAPER Nannenga BL, Zameer A, Sierks MR

Anti-oligomeric single chain variable domain antibody differentially affects huntingtin and alpha-synuclein aggregates.

FEBS Lett. 2008 Feb 20;582(4):517-22. PubMed: 18230361